Direct oral anticoagulants for unusual‐site venous thromboembolism

Abstract Direct oral anticoagulants (DOACs) are currently the preferred oral anticoagulant treatment for most of the patients with deep vein thrombosis of the lower extremities and/or pulmonary embolism. DOACs have several advantages over vitamin K antagonists, such as availability of fixed dosages,...

Full description

Bibliographic Details

Published in:	Research and Practice in Thrombosis and Haemostasis
Main Authors:	Nicoletta Riva, Walter Ageno
Format:	Article
Language:	English
Published:	Elsevier 2021-02-01
Subjects:	Budd‐Chiari syndrome cranial sinus thrombosis direct‐acting oral anticoagulants portal vein upper extremity deep vein thrombosis venous thromboembolism
Online Access:	https://doi.org/10.1002/rth2.12480